Related Experiment Video
Updated: Aug 24, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Total synthesis of antiviral drug, nirmatrelvir (PF-07321332)
Chandra Shekhar1,2, Rajesh Nasam1,2, Siva Ramakrishna Paipuri1,2
1Department of Organic Synthesis and Process Chemistry, CSIR-Indian Institute of Chemical Technology, Hyderabad, 500007, India.
Abstract:
The emergence and rapid spread of coronavirus disease 2019 (COVID-19), a potentially fatal disease, caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has swiftly led to public health crisis worldwide. Hence vaccines and antiviral therapeutics are an important part of the healthcare response to combat the ongoing threat by COVID-19. Here, we report an efficient synthesis of nirmatrelvir (PF-07321332), an orally active SARS-CoV-2 main protease inhibitor.
Related Concept Videos
Subviral Agents
Retrovirus Life Cycles
Retroviruses
Antimicrobial Effectiveness

